NCOA1
Nuclear receptor coactivator 1
Also known as: bHLHe74, F-SRC-1, KAT13A, NCoA-1, NCOA1_HUMAN, RIP160, SRC1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15788
- Gene
- NCOA1
- Ensembl
- ENSG00000084676
- Chromosome
- 2
- Canonical length
- 1441 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene acts as a transcriptional coactivator for steroid and nuclear hormone receptors. It is a member of the p160/steroid receptor coactivator (SRC) family and like other family members has histone acetyltransferase activity and contains a nuclear localization signal, as well as bHLH and PAS domains. The product of this gene binds nuclear receptors directly and stimulates the transcriptional activities in a hormone-dependent fashion. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1441 residues, UniProt reviewed canonical sequence.
>Q15788|NCOA1
1 MSGLGDSSSD PANPDSHKRK GSPCDTLASS TEKRRREQEN KYLEELAELL SANISDIDSL
61 SVKPDKCKIL KKTVDQIQLM KRMEQEKSTT DDDVQKSDIS SSSQGVIEKE SLGPLLLEAL
121 DGFFFVVNCE GRIVFVSENV TSYLGYNQEE LMNTSVYSIL HVGDHAEFVK NLLPKSLVNG
181 VPWPQEATRR NSHTFNCRML IHPPDEPGTE NQEACQRYEV MQCFTVSQPK SIQEDGEDFQ
241 SCLICIARRL PRPPAITGVE SFMTKQDTTG KIISIDTSSL RAAGRTGWED LVRKCIYAFF
301 QPQGREPSYA RQLFQEVMTR GTASSPSYRF ILNDGTMLSA HTKCKLCYPQ SPDMQPFIMG
361 IHIIDREHSG LSPQDDTNSG MSIPRVNPSV NPSISPAHGV ARSSTLPPSN SNMVSTRINR
421 QQSSDLHSSS HSNSSNSQGS FGCSPGSQIV ANVALNQGQA SSQSSNPSLN LNNSPMEGTG
481 ISLAQFMSPR RQVTSGLATR PRMPNNSFPP NISTLSSPVG MTSSACNNNN RSYSNIPVTS
541 LQGMNEGPNN SVGFSASSPV LRQMSSQNSP SRLNIQPAKA ESKDNKEIAS ILNEMIQSDN
601 SSSDGKPLDS GLLHNNDRLS DGDSKYSQTS HKLVQLLTTT AEQQLRHADI DTSCKDVLSC
661 TGTSNSASAN SSGGSCPSSH SSLTERHKIL HRLLQEGSPS DITTLSVEPD KKDSASTSVS
721 VTGQVQGNSS IKLELDASKK KESKDHQLLR YLLDKDEKDL RSTPNLSLDD VKVKVEKKEQ
781 MDPCNTNPTP MTKPTPEEIK LEAQSQFTAD LDQFDQLLPT LEKAAQLPGL CETDRMDGAV
841 TSVTIKSEIL PASLQSATAR PTSRLNRLPE LELEAIDNQF GQPGTGDQIP WTNNTVTAIN
901 QSKSEDQCIS SQLDELLCPP TTVEGRNDEK ALLEQLVSFL SGKDETELAE LDRALGIDKL
961 VQGGGLDVLS ERFPPQQATP PLIMEERPNL YSQPYSSPSP TANLPSPFQG MVRQKPSLGT
1021 MPVQVTPPRG AFSPGMGMQP RQTLNRPPAA PNQLRLQLQQ RLQGQQQLIH QNRQAILNQF
1081 AATAPVGINM RSGMQQQITP QPPLNAQMLA QRQRELYSQQ HRQRQLIQQQ RAMLMRQQSF
1141 GNNLPPSSGL PVQMGNPRLP QGAPQQFPYP PNYGTNPGTP PASTSPFSQL AANPEASLAN
1201 RNSMVSRGMT GNIGGQFGTG INPQMQQNVF QYPGAGMVPQ GEANFAPSLS PGSSMVPMPI
1261 PPPQSSLLQQ TPPASGYQSP DMKAWQQGAI GNNNVFSQAV QNQPTPAQPG VYNNMSITVS
1321 MAGGNTNVQN MNPMMAQMQM SSLQMPGMNT VCPEQINDPA LRHTGLYCNQ LSSTDLLKTE
1381 ADGTQQVQQV QVFADVQCTV NLVGGDPYLN QPGPLGTQKP TSGPQTPQAQ QKSLLQQLLT
1441 ELocalizationUniProt · AlphaFold · HPA
Whether an antibody against NCOA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 43 nTPM
Expression across tissuesHPA
Tissue
- retina: 43 nTPM
- tongue: 33 nTPM
- skeletal muscle: 32 nTPM
- parathyroid gland: 28 nTPM
- thymus: 24 nTPM
- cerebral cortex: 23 nTPM
Single-cell type
- neutrophils: 2,075 nCPM
- bergmann glia: 1,220 nCPM
- myonuclei: 1,084 nCPM
- thyrotrophs: 1,067 nCPM
- retinal bipolar cells: 760 nCPM
- rod photoreceptor cells: 743 nCPM
Immune cell
- neutrophil: 14 nTPM
- basophil: 11 nTPM
- eosinophil: 7 nTPM
- plasmacytoid DC: 5.2 nTPM
- MAIT T-cell: 3.8 nTPM
- memory CD8 T-cell: 3.7 nTPM
Brain region
- hippocampal formation: 79 nTPM
- cerebral cortex: 76 nTPM
- basal ganglia: 69 nTPM
- cerebellum: 68 nTPM
- amygdala: 67 nTPM
- thalamus: 65 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.25
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.35
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to hormone stimulus
- cellular response to Thyroglobulin triiodothyronine
- cerebellum development
- cerebral cortex development
- estrogen receptor signaling pathway
- estrous cycle
- hippocampus development
- hypothalamus development
- labyrinthine layer morphogenesis
- lactation
- male gonad development
- male mating behavior
- mRNA transcription by RNA polymerase II
- peroxisome proliferator activated receptor signaling pathway
- positive regulation of adipose tissue development
- positive regulation of apoptotic process
- positive regulation of DNA-templated transcription
- positive regulation of female receptivity
- positive regulation of neuron differentiation
- positive regulation of transcription by RNA polymerase II
- progesterone receptor signaling pathway
- regulation of cellular response to insulin stimulus
- regulation of thyroid hormone receptor signaling pathway
- response to estradiol
- response to progesterone
- response to retinoic acid
- positive regulation of transcription from RNA polymerase II promoter by galactose
Molecular functions
- chromatin binding
- nuclear estrogen receptor binding
- nuclear receptor binding
- nuclear retinoid X receptor binding
- protein dimerization activity
- protein-containing complex binding
- protein-lysine-acetyltransferase activity
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- transcription coactivator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- PAS domain
- Nuclear receptor coactivator, interlocking
- Nuclear receptor coactivator, DUF1518
- Myc-type, basic helix-loop-helix (bHLH) domain
- PAS fold
- Nuclear receptor coactivator, Ncoa-type, interlocking
- Nuclear receptor coactivator, receptor-binding domain
- Nuclear receptor coactivator
- PAS domain superfamily
- Helix-loop-helix DNA-binding domain superfamily
- Nuclear receptor coactivator, Ncoa-type, interlocking domain superfamily
- Nuclear receptor coactivator 1-3, bHLH domain
- PAS fold
- Nuclear receptor coactivator, DUF1518
- Nuclear receptor coactivator
- Steroid receptor coactivator
- PAS domain
- Unstructured region on nuclear receptor coactivator protein
- Nuclear receptor coactivators bHLH domain
- Nuclear receptor coactivator 1, basic helix-loop-helix
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NCOA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NCOA1 as an antibody target. Whether an autoantibody or antibody against NCOA1 could matter depends on whether native NCOA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NCOA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NCOA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...